A Broader, More Integrated Vision of Diabetes Care The 2026 ADA Standards move decisively toward: Integration rather than silos Early intervention rather than rescue Personalized strategies over rigid targets They align closely with a common-sense, balanced viewpoint of metabolic health
degludec assoc with: Liver fat content (LFC) 18-28% Both in either HbA1c or weight assoc with Both the visceral & subcutaneous abdominal fat equally ALT 4-22% AST 10-19% SURPASS-3 MRI trial (3/3) tirzepatide (particularly 10-15mg doses) looks to be possible treatments for #NAFLD #NASH, as well as #type2diabetes ongoing liver outcome RCT with liver biopsy clinicaltrials.gov/ct2/show/NCT04 SURPASS-3 CGM (1/2) another sub-study of SURPASS-3 (n=243) Dexcom G6 CGM used 1ry outcome - Time within Tight Target range 3.9-7.8 mmol/mol (71-140 mg/dL) at 24 + 52w % time within standard target range 3.9-10 mmol/mol (71-180 mg/dL) at 52w Presented by @TBattelino SURPASS - CGM (2/2) tirzepatide treatment assoc with: Marked in Tight TIR compared to ins
It is always best to err on the side of caution and consult a doctor in these life stages
You may notice: Nausea, often when starting or increasing the dose A reduced appetite, which supports weight loss Mild stomach discomfort, constipation, or diarrhea Temporary fatigue during early treatment Eating smaller meals, avoiding high-fat foods, and staying hydrated help minimize these effects
Rubbing can irritate the skin, spread blood under the surface, and make tenderness or bruising worse
Berberine is a bioactive compound extracted from several plants, including Berberis vulgaris (barberry), Berberis aristata (tree turmeric), and Coptis chinensis (goldenseal)
